Cardiotoxicity with rituximab, cyclophosphamide, non-pegylated liposomal doxorubicin, vincristine and prednisolone compared to rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisolone in frontline treatment of patients with diffuse large B-cell lymphoma: A randomised phase-III study from the Austrian Cancer Drug Therapy Working Group [Arbeitsgemeinschaft Medikamentöse Tumortherapie AGMT](NHL-14).

Fridrik, MA; Jaeger, U; Petzer, A; Willenbacher, W; Keil, F; Lang, A; Andel, J; Burgstaller, S; Krieger, O; Oberaigner, W; Sihorsch, K; Greil, R; Eur J Cancer. 2016; 58:-21

Elevated Toll-Like Receptor-Induced CXCL8 Secretion in Human Blood Basophils from Allergic Donors Is Independent of Toll-Like Receptor Expression Levels.

Steiner, M; Hawranek, T; Schneider, M; Ferreira, F; Horejs-Hoeck, J; Harrer, A; Himly, M; PLOS ONE. 2016; 11(2): e0149275

The AKT1 isoform plays a dominant role in the survival and chemoresistance of chronic lymphocytic leukaemia cells.

Hofbauer, SW; Krenn, PW; Piñόn Hofbauer, J; Pucher, S; Asslaber, D; Egle, A; Hartmann, TN; Greil, R; Br J Haematol. 2016; 172(5):815-819

An international, multicenter, prospective, observational study of neutropenia in patients being treated with lenalidomide + dexamethasone for relapsed or relapsed/refractory multiple myeloma (RR-MM).

Leleu, X; Terpos, E; Sanz, RG; Cooney, J; OGorman, P; Minarik, J; Greil, R; Williams, C; Gray, D; Szabo, Z; Am J Hematol. 2016; 91(8):806-811

Rituximab maintenance versus observation alone in patients with chronic lymphocytic leukaemia who respond to first-line or second-line rituximab-containing chemoimmunotherapy: final results of the AGMT CLL-8a Mabtenance randomised trial.

Greil, R; Obrtlíková, P; Smolej, L; Kozák, T; Steurer, M; Andel, J; Burgstaller, S; Mikušková, E; Gercheva, L; Nösslinger, T; Papajík, T; Ladická, M; Girschikofsky, M; Hrubiško, M; Jäger, U; Fridrik, M; Pecherstorfer, M; Králiková, E; Burcoveanu, C; Spasov, E; Petzer, A; Mihaylov, G; Raynov, J; Oexle, H; Zabernigg, A; Flochová, E; Palášthy, S; Stehlíková, O; Doubek, M; Altenhofer, P; Pleyer, L; Melchardt, T; Klingler, A; Mayer, J; Egle, A; Lancet Haematol. 2016; 3(7):e317-e329

The Evolution of Human Basophil Biology from Neglect towards Understanding of Their Immune Functions.

Steiner, M; Huber, S; Harrer, A; Himly, M; Biomed Res Int. 2016; 2016: 8232830

Cancer-Related Fatigue in Patients With and Survivors of Hodgkin Lymphoma: The Impact on Treatment Outcome and Social Reintegration.

Behringer, K; Goergen, H; Müller, H; Thielen, I; Brillant, C; Kreissl, S; Halbsguth, TV; Meissner, J; Greil, R; Moosmann, P; Shonukan, O; Rueffer, JU; Flechtner, HH; Fuchs, M; Diehl, V; Engert, A; Borchmann, P; J Clin Oncol. 2016; 34(36):4329-4337

Epidermal-specific deletion of CD44 reveals a function in keratinocytes in response to mechanical stress.

Shatirishvili, M; Burk, AS; Franz, CM; Pace, G; Kastilan, T; Breuhahn, K; Hinterseer, E; Dierich, A; Bakiri, L; Wagner, EF; Ponta, H; Hartmann, TN; Tanaka, M; Orian-Rousseau, V; Cell Death Dis. 2016; 7(11): e2461

Basophil Reactivity as Biomarker in Immediate Drug Hypersensitivity Reactions-Potential and Limitations.

Steiner, M; Harrer, A; Himly, M; Front Pharmacol. 2016; 7: 171

Effect of Tailored Dose-Dense Chemotherapy vs Standard 3-Weekly Adjuvant Chemotherapy on Recurrence-Free Survival Among Women With High-Risk Early Breast Cancer: A Randomized Clinical Trial.

Foukakis, T; von Minckwitz, G; Bengtsson, NO; Brandberg, Y; Wallberg, B; Fornander, T; Mlineritsch, B; Schmatloch, S; Singer, CF; Steger, G; Egle, D; Karlsson, E; Carlsson, L; Loibl, S; Untch, M; Hellström, M; Johansson, H; Anderson, H; Malmström, P; Gnant, M; Greil, R; Möbus, V; Bergh, J; JAMA. 2016; 316(18):-1896